Website: N/A
Stock Symbol: NASDAQ: ASTM
Market Value: N/A (in millions)
We are a regenerative medicine company (a medical area that focuses on
developing therapies that regenerate damaged or diseased tissues or organs)
focused on the clinical development of autologous cell products (cells collected
from a patient and returned to that same patient) for the repair or regeneration
of multiple human tissues, based on proprietary Tissue Repair Cell (TRC)
Technology. Our preclinical and clinical product development programs utilize
patient-derived bone marrow stem and early progenitor cell populations, and are
being investigated for their ability to aid in the regeneration of tissues such
as bone, vascular, cardiac and neural. TRC-based products have been used in over
250 patients, and are currently in the following stages of development:
• Bone regeneration — Bone Repair Cells (BRCs):
• Osteonecrosis of the femoral head:
• U.S.